UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment Journal article
ACTA PHARMACEUTICA SINICA B, 2019,Volume: 9,Issue: 2,Page: 203-219
Authors:  Xu Wu;  Wei Hu;  Lan Lu;  Yueshui Zhao;  Yejiang Zhou;  Zhangang Xiao;  Lin Zhang;  Hanyu Zhang;  Xiaobing Li;  Wanping Li;  Shengpeng Wang;  Chi Hin Cho;  Jing Shen;  Mingxing Li
Favorite | View/Download:12/0 | TC[WOS]:5 TC[Scopus]:14 | Submit date:2020/04/01
Vitamin d  1α,25-dihydroxyvitamin D3  Tumor Microenvironment  Cancer Stem Cell  Tumor-infiltrating Lymphocyte  Tumor-derived Endothelial Cell  Cancer-associated Fibroblast  
Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing Journal article
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018,Volume: 143,Page: 1021-1027
Authors:  Wu, Ke-Jia;  Zhong, Hai-Jing;  Li, Guodong;  Liu, Chenfu;  Wang, Hui-Min David;  Ma, Dik-Lung;  Leung, Chung-Hang
Favorite | View/Download:29/0 | TC[WOS]:25 TC[Scopus]:32 | Submit date:2018/10/30
Drug Repurposing  Mitoxantrone  Nedd8  Ubiquitin  
Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer Journal article
British Journal of Pharmacology, 2014,Volume: 171,Issue: 19,Page: 4478-4489
Authors:  Wang M.;  Shim J.S.;  Li R.-J.;  Dang Y.;  He Q.;  Das M.;  Liu J.O.
Favorite | View/Download:12/0 | TC[WOS]:17 TC[Scopus]:17 | Submit date:2019/01/15
Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells Journal article
Breast Cancer Research, 2014,Volume: 16,Issue: 3
Authors:  Vazquez-Ortiz G.;  Chisholm C.;  Xu X.;  Lahusen T.J.;  Li C.;  Sakamuru S.;  Huang R.;  Thomas C.J.;  Xia M.;  Deng C.
Favorite | View/Download:15/0 | TC[WOS]:11 TC[Scopus]:12 | Submit date:2018/12/13
Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme Journal article
Biochimie, 2014,Volume: 102,Issue: 1,Page: 211-215
Authors:  Zhong H.-J.;  Liu L.-J.;  Chan D.S.-H.;  Wang H.-M.;  Chan P.W.H.;  Ma D.-L.;  Leung C.-H.
Favorite | View/Download:11/0 | TC[WOS]:14 TC[Scopus]:17 | Submit date:2018/11/06
Inhibitor  Nedd8-activating Enzyme  Repurposing  Structure-based  Virtual Screening  
Recent advances in drug repositioning for the discovery of new anticancer drugs Journal article
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2014,Volume: 10,Issue: 7,Page: 654-663
Authors:  Joong Sup Shim;  Jun O. Liu
Favorite | View/Download:6/0 | TC[WOS]:135 TC[Scopus]:177 | Submit date:2019/01/24
Drug Repositioning  Drug Discovery  Cancer  Angiogenesis  Drug Screening  Drug Library  
Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer Journal article
Biochimie, 2011,Volume: 93,Issue: 6,Page: 1055-1064
Authors:  Chan D.S.-H.;  Yang H.;  Kwan M.H.-T.;  Cheng Z.;  Lee P.;  Bai L.-P.;  Jiang Z.-H.;  Wong C.-Y.;  Fong W.-F.;  Leung C.-H.;  Ma D.-L.
Favorite | View/Download:10/0 | TC[WOS]:65 TC[Scopus]:70 | Submit date:2018/11/06
c-myc G-quadruplex  FDA-approved drug  Methylene blue  Repurposing  Structure-based optimization  
Structure-based repurposing of FDA-approved drugs as TNF-α inhibitors Journal article
ChemMedChem, 2011,Volume: 6,Issue: 5,Page: 765-768
Authors:  Leung C.-H.;  Chan D.S.-H.;  Kwan M.H.-T.;  Cheng Z.;  Wong C.-Y.;  Zhu G.-Y.;  Fong W.-F.;  Ma D.-L.
Favorite | View/Download:3/0 | TC[WOS]:35 TC[Scopus]:37 | Submit date:2018/11/06
Approved drugs  Drug discovery  Inhibitors  Tumor necrosis factor  Virtual screening